Dose-ranging effects of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and meta-analysis

被引：0
|
作者：
Pinto, L. C. [1 ]
Rados, D. R. [1 ]
Retnonti, L. R. [1 ]
Viana, M. V. [1 ]
Leitao, C. B. [1 ]
Gross, J. L. [1 ]
机构：
[1] Univ Fed Rio Grande do Sul, Endocrine Div, Porto Alegre, RS, Brazil
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
645
引用
收藏
页码：S313 / S313
页数：1
相关论文
共 50 条
  • [21] The Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in Diabetic Patients: A Systematic Review and Meta-Analysis
    Lo, Kevin Bryan
    Gul, Fahad
    Ram, Pradhum
    Kluger, AaronY.
    Tecson, KristenM.
    McCullough, PeterA.
    Rangaswami, Janani
    CARDIORENAL MEDICINE, 2020, 10 (01) : 1 - 10
  • [22] SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials
    Wen-jie Li
    Xing-qing Chen
    Ling-ling Xu
    Yuan-qing Li
    Bi-hui Luo
    Cardiovascular Diabetology, 19
  • [23] SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials
    Li, Wen-jie
    Chen, Xing-qing
    Xu, Ling-ling
    Li, Yuan-qing
    Luo, Bi-hui
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [24] SGLT2 INHIBITORS COMPARED WITH SITAGLIPTIN AS ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Sevald, C. A.
    Jackson, J. D.
    Mcana, J. F.
    VALUE IN HEALTH, 2016, 19 (03) : A197 - A197
  • [25] SGLT2 Inhibitors versus Sulfonylureas as Add-On Therapy to Metformin in Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Umer, Muhammed
    Salman, Ali
    Nadeem, Shahrukh
    Iqbal, Abiha
    Tashrifwala, Fatema
    Paryani, Neha Saleem
    Ali, Eman
    Kumar, Jai
    Maniya, Muhammad Talha
    Asad, Dayab
    CIRCULATION, 2023, 148
  • [26] SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits
    Elisa Marilly
    Judith Cottin
    Natalia Cabrera
    Catherine Cornu
    Remy Boussageon
    Philippe Moulin
    Jean-Christophe Lega
    François Gueyffier
    Michel Cucherat
    Guillaume Grenet
    Diabetologia, 2022, 65 : 2000 - 2010
  • [27] Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Type 1 Diabetes: A Systematic Review and Meta-analysis
    El Masri, Dana
    Jaber, Linda
    DIABETES, 2017, 66 : LB41 - LB41
  • [28] SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits
    Marilly, Elisa
    Cottin, Judith
    Cabrera, Natalia
    Cornu, Catherine
    Boussageon, Remy
    Moulin, Philippe
    Lega, Jean-Christophe
    Gueyffier, Francois
    Cucherat, Michel
    Grenet, Guillaume
    DIABETOLOGIA, 2022, 65 (12) : 2000 - 2010
  • [29] Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Xin Wang
    Fengyi Zhang
    Yufeng Zhang
    Jiayi Zhang
    Yingli Sheng
    Wenbo Wang
    Yujie Li
    Osteoporosis International, 2023, 34 : 2013 - 2025
  • [30] Risk of diabetic ketoacidosis of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials
    Yang, Shiwen
    Liu, Ying
    Zhang, Shengzhao
    Wu, Fengbo
    Liu, Dan
    Wu, Qingfang
    Zheng, Hanrui
    Fan, Ping
    Su, Na
    FRONTIERS IN PHARMACOLOGY, 2023, 14
12345